Biography

Dr. David Browning is a board-certified ophthalmologist who focuses on vitreoretinal diseases and surgery, macular degeneration, and the retina in the Charlotte, NC and Concord, NC areas. He is board-certified by the American Board of Ophthalmology. He has authored and co-authored more than 120 papers in peer-reviewed journals and has written and edited three textbooks.

Dr. Browning practices in our SouthPark (6035 Fairview Road, Charlotte, NC) and Concord (645 Amalia Street NE, Concord, NC) offices. To make an appointment with him, call 704-295-3000. You can also request an appointment online or through myCEENTAchart.


Education & Fellowship

Undergraduate
Harvard University, 1975

PhD and Medical
Duke University, 1980 and 1981, respectively

Internship
Duke University Medical Center, 1982

Residency
Ophthalmology, Duke University Eye Center, 1985

Fellowship
Vitreoretinal diseases, Bascom Palmer Eye Institute, University of Miami, 1986


Associations & Memberships

Board Certified by:
- American Board of Ophthalmology

Member of:
- American Board of Ophthalmology, Examiner and Mentor Examiner
- American Academy of Ophthalmology, Fellow
- American Ophthalmological Society
- Executive Editor of the American Journal of Ophthalmology and Editorial Board member of Retina


Community Involvement

Dr. Browning has given continuing education talks including:

"Melanoma, Mecklenburg... and More"
"OCT Omnibus - Cases That Will Make You Sharper in Clinic"
"Screening for Hydroxychloroquine Retinopathy in 2018"
"Retinal Cases with a Point"


Research

Dr. Browning has authored and co-authored more than 120 papers in peer-reviewed journals including: Diabetic macular edema: Evidence-based management.

Browning DJ, Stewart MW, Lee C. Indian J Ophthalmol. 2018 Dec;66(12):1736-1750. doi: 10.4103/ijo.IJO_1240_18.

He is the author and editor of three textbooks including: Hydroxychloroquine and Chloroquine Retinopathy, published in 2014.

He has directed/participated in more than 35 clinical research trials and is currently enrolling patients in trials for treatments of diabetic retinopathy and vitreomacular traction syndrome.


This website is optimized for more recent web browsers. Please consider these upgrade options: IE10+ (), Chrome (), Firefox ().